The Glycophosphatidylinositol Anchor of the MCMV Evasin, m157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor Recognition

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Carlin, Lindsey E ^a,b   Guseva, Natalya V ^b   Shey, Michael R ^a   Ballas, Zuhair K ^a,b   Heusel, Jonathan W ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RECEPTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; HYBRID PROTEIN; LYSINE RECEPTOR; M157 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A; VIRAL PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL SURFACE; CONTROLLED STUDY; CYTOMEGALOVIRUS; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CYTOTOXICITY; DOWN REGULATION; IMMUNOLOGY; METABOLISM; MOUSE; MUROMEGALOVIRUS; NATURAL KILLER CELL;

MAIZE CHLOROTIC MOTTLE VIRUS; MURID HERPESVIRUS 1;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; GLYCOSYLPHOSPHATIDYLINOSITOLS; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MUROMEGALOVIRUS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; VIRAL PROTEINS;

EID: 84879243461     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067295     Document Type: Article

References (50)

1. Colonna M, Jonjic S, Watzl C, (2011) Natural killer cells: fighting viruses and much more. Nat Immunol 12: 107-110.
2. Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, et al. (2008) NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28: 571-580.
3. Hayakawa Y, (2012) Targeting NKG2D in tumor surveillance. Expert Opin Ther Targets 16: 587-599.
4. Souza-Fonseca-Guimaraes F, Adib-Conquy M, Cavaillon JM, (2012) Natural killer (NK) cells in antibacterial innate immunity: angels or devils? Mol Med 18: 270-285.
5. Stojanovic A, Cerwenka A, (2011) Natural killer cells and solid tumors. J Innate Immun 3: 355-364.
6. Yokoyama WM, Altfeld M, Hsu KC, (2010) Natural killer cells: tolerance to self and innate immunity to viral infection and malignancy. Biol Blood Marrow Transplant 16: S97-S105.
7. Orr MT, Lanier LL, (2011) Inhibitory Ly49 receptors on mouse natural killer cells. Curr Top Microbiol Immunol 350: 67-87.
8. Back J, Malchiodi EL, Cho S, Scarpellino L, Schneider P, et al. (2009) Distinct conformations of Ly49 natural killer cell receptors mediate MHC class I recognition in trans and cis. Immunity 31: 598-608.
9. Chalifour A, Scarpellino L, Back J, Brodin P, Devevre E, et al. (2009) A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 30: 337-347.
10. Doucey MA, Scarpellino L, Zimmer J, Guillaume P, Luescher IF, et al. (2004) Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat Immunol 5: 328-336.
11. Eriksson M, Leitz G, Fallman E, Axner O, Ryan JC, et al. (1999) Inhibitory receptors alter natural killer cell interactions with target cells yet allow simultaneous killing of susceptible targets. J Exp Med 190: 1005-1012.
12. Elliott JM, Yokoyama WM, (2011) Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol 32: 364-372.
13. Raulet DH, Held W, Correa I, Dorfman JR, Wu MF, et al. (1997) Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 155: 41-52.
14. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL, (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
15. Tripathy SK, Smith HR, Holroyd EA, Pingel JT, Yokoyama WM, (2006) Expression of m157, a murine cytomegalovirus-encoded putative major histocompatibility class I (MHC-I)-like protein, is independent of viral regulation of host MHC-I. J Virol 80: 545-550.
16. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, et al. (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 99: 8826-8831.
17. Lee SH, Girard S, Macina D, Busa M, Zafer A, et al. (2001) Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 28: 42-45.
18. Corbett AJ, Coudert JD, Forbes CA, Scalzo AA, (2011) Functional consequences of natural sequence variation of murine cytomegalovirus m157 for Ly49 receptor specificity and NK cell activation. J Immunol 186: 1713-1722.
19. Scalzo AA, Corbett AJ, Rawlinson WD, Scott GM, Degli-Esposti MA, (2007) The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol Cell Biol 85: 46-54.
20. Paulick MG, Bertozzi CR, (2008) The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins. Biochemistry 47: 6991-7000.
21. Horejsi V, Drbal K, Cebecauer M, Cerny J, Brdicka T, et al. (1999) GPI-microdomains: a role in signalling via immunoreceptors. Immunol Today 20: 356-361.
22. Brown DA, (2006) Lipid rafts, detergent-resistant membranes, and raft targeting signals. Physiology (Bethesda) 21: 430-439.
23. Simons K, Toomre D, (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1: 31-39.
24. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, et al. (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729.
25. Chiang EY, Henson M, Stroynowski I, (2002) The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokine-activated killer cell-mediated cytolysis. J Immunol 168: 2200-2211.
26. Gonzalez S, Lopez-Soto A, Suarez-Alvarez B, Lopez-Vazquez A, Lopez-Larrea C, (2008) NKG2D ligands: key targets of the immune response. Trends Immunol 29: 397-403.
27. Nausch N, Cerwenka A, (2008) NKG2D ligands in tumor immunity. Oncogene 27: 5944-5958.
28. Champsaur M, Lanier LL, (2010) Effect of NKG2D ligand expression on host immune responses. Immunol Rev 235: 267-285.
29. Gasser S, Raulet D, (2006) The DNA damage response, immunity and cancer. Semin Cancer Biol 16: 344-347.
30. Raulet DH, (2003) Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3: 781-790.
31. Takada A, Yoshida S, Kajikawa M, Miyatake Y, Tomaru U, et al. (2008) Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D. J Immunol 180: 1678-1685.
32. Martinez E, Brzostowski JA, Long EO, Gross CC, (2011) Cutting edge: NKG2D-dependent cytotoxicity is controlled by ligand distribution in the target cell membrane. J Immunol 186: 5538-5542.
33. Fernandez-Messina L, Ashiru O, Aguera-Gonzalez S, Reyburn HT, Vales-Gomez M, (2011) The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells. J Cell Sci 124: 321-327.
34. Davis AH, Guseva NV, Ball BL, Heusel JW, (2008) Characterization of murine cytomegalovirus m157 from infected cells and identification of critical residues mediating recognition by the NK cell receptor Ly49H. J Immunol 181: 265-275.
35. Guseva NV, Fullenkamp CA, Naumann PW, Shey MR, Ballas ZK, et al. (2010) Glycosylation contributes to variability in expression of murine cytomegalovirus m157 and enhances stability of interaction with the NK-cell receptor Ly49H. Eur J Immunol 40: 2618-2631.
36. Shey MR, Ballas ZK, (2008) Assessment of natural killer (NK) and NKT cells in murine spleens and livers. Methods Mol Biol 447: 259-276.
37. Natarajan K, Dimasi N, Wang J, Mariuzza RA, Margulies DH, (2002) Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 20: 853-885.
38. Jacobs MG, Robinson PJ, Bletchly C, Mackenzie JM, Young PR, (2000) Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB J 14: 1603-1610.
39. Cheng TP, French AR, Plougastel BF, Pingel JT, Orihuela MM, et al. (2008) Ly49h is necessary for genetic resistance to murine cytomegalovirus. Immunogenetics 60: 565-573.
40. Bubic I, Wagner M, Krmpotic A, Saulig T, Kim S, et al. (2004) Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol 78: 7536-7544.
41. Sumaria N, van Dommelen SL, Andoniou CE, Smyth MJ, Scalzo AA, et al. (2009) The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity. Immunol Cell Biol 87: 559-566.
42. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, et al. (2001) Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2: 951-956.
43. Ceresa BP, Schmid SL, (2000) Regulation of signal transduction by endocytosis. Curr Opin Cell Biol 12: 204-210.
44. Sorkin A, von Zastrow M, (2009) Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 10: 609-622.
45. Perussia B, (2000) Signaling for cytotoxicity. Nat Immunol 1: 372-374.
46. Cella M, Fujikawa K, Tassi I, Kim S, Latinis K, et al. (2004) Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J Exp Med 200: 817-823.
47. Kinoshita T, Fujita M, Maeda Y, (2008) Biosynthesis, remodelling and functions of mammalian GPI-anchored proteins: recent progress. J Biochem 144: 287-294.
48. Maeda Y, Kinoshita T, (2011) Structural remodeling, trafficking and functions of glycosylphosphatidylinositol-anchored proteins. Prog Lipid Res 50: 411-424.
49. Barreira da Silva R, Munz C, (2011) Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals. Cell Mol Life Sci 68: 3505-3518.
50. Kaplan A, Kotzer S, Almeida CR, Kohen R, Halpert G, et al. (2011) Simulations of the NK cell immune synapse reveal that activation thresholds can be established by inhibitory receptors acting locally. J Immunol 187: 760-773.